2020 edition of the Chinese Pharmacopeia was officially promulgated! Implemented on 30 December

Guide: A total of 5911 varieties were collected, 319 new species were added, and 3177 were revisedjust now, the State Drug Administration and the National Health and Health Administration jointly issued an announcement on the publication of the 2020 edition of the Pharmacopoeia of the People's Republic of China (No78 of 2020)The 2020 edition of the Pharmacopeia of the People's Republic of China (hereinafter referred to as the Chinese Pharmacopoeia) was officially promulgatedThe 2020 edition of the Chinese Pharmacopoeia will be officially implemented on December 30 this yearThe Chinese Pharmacopoeia was created by the State Pharmacopeia Commission to ensure the controlled quality of medicines and the Drug Code for the safety and effectiveness of the people's use of drugsAs the core of the national drug standard system, the pharmacopeia covers basic drugs, medical insurance catalogue varieties and clinically commonly used drugs, and its setting makes the development, production, operation, use and management of drugs all the links to achieve law-based, legal compliance, strict legal basis also strengthens the control of drug safety and effectivenessAccording to the National Pharmacopeia Commission, in 2020 the new edition of the Pharmacopoeia added 319 kinds, revised 3177 species, no longer loaded 10 species, varieties adjusted and combined 4 species, a total of 5911 varietiesOne Chinese medicine contains 2711 kinds, of which 117 are added and 452 are revisedTwo chemical strains contained 2712 kinds, of which 117 were added and 2387 were revisedThree biological products contain 153 species, of which 20 new, revised 126 species; The four collection of general technical requirements 361, of which 38 (revised 35), testing methods and other general rules 281 (35 new, revised 51), 42 guiding principles (12 new, revised 12);Table 1 China Pharmacopeia 2015 and 2020 edition of the collection situation comparison
picture source: the National Pharmacopeia Commission67 years ago in 1953, China promulgated the first edition of the Chinese Pharmacopoeia, and has since maintained every 5 years issued a version, the new version of the "China Pharmacopoie" once promulgated and implemented, the same variety of the original national drug standards self-repeal, the 2020 edition is the 11th edition so farcompared with the 5608 editions of the 2015 edition of the Pharmacopeia, the new edition of the Pharmacopeia received 5.5% increaseThe new edition of the pharmacopeia variety collection adheres to the clinical demand-oriented, further expand the national basic drug catalog and the national basic medical insurance drug catalog varieties, the quality of clinically commonly used drugs to be further guaranteed (See Figure 1)Timely collection of biopharmaceutical compaq, polio inactivated vaccine and other newly listed varieties, fully reflect the latest achievements of China's pharmaceutical innovation and research and development Table 2 1953-2020 edition of the "Chinese Pharmacopoeia" collection of varieties list Picture Source: State Pharmacopeia Commission 2020 edition of the "China Pharmacopoeia" in addition to steadily advancing the collection of pharmacopeia varieties, the Pharmacopeia The standard system is further improved, the application of mature analytical and testing technology is further expanded, the requirements of drug safety control are constantly strengthened, the drug effectiveness control is constantly improved, the whole process quality control system is gradually constructed, the standard level of accessories is further enhanced, the international standard coordination is further strengthened, and the role of pharmacopeia-oriented is further strengthened (Details can be seen
"Set!" The 2020 edition of the Pharmacopoeia was officially implemented on December 1, 2020 ) to borrow from the speech of The State Administration of Drug Administration, Jia Hong: "The 2020 edition of the Chinese Pharmacopoeia has steadily promoted the collection of pharmacopeia varieties, further meeting the needs of the national basic drug catalogue and basic medical insurance catalogue varieties." The national drug standard system is becoming more and more perfect, the standard level of drug has been significantly improved, the drug safety requirements have been continuously strengthened, and the guiding effect is becoming more and more obvious Its promulgation and implementation will be conducive to the overall promotion of China's drug standards level, further ensure the safety of public drug use, promote the adjustment of the pharmaceutical industry structure, promote China's pharmaceutical products to the international, to achieve the leap from a pharmaceutical power to a pharmaceutical power "
source of information: The National Pharmacopeia Commission, the State Drug Administration and other public information